BioCentury
ARTICLE | Company News

Atlantic Technology, Manhattan deal

December 23, 2002 8:00 AM UTC

ATLC will merge with Manhattan, which develops therapeutics for obesity. Upon completion of the merger, ATLC shareholders will own about 20% and Manhattan will own about 80% of the combined company. M...